Investment in Indian pharma companies during COVID 19 lockdowns in Q2 2020
European Journal of Molecular & Clinical Medicine,
2020, Volume 7, Issue 9, Pages 3204-3210
AbstractThis project covers the entire scenario of how likely were the investments in pharma companies during the time period of lockdown due to the outburst of COVID-19. It covers an entire research, it’s results, conclusions and all the analysis based on the investment in pharma companies. Ultimate aim was to analyze the impact of the COVID-19 scenario. The regular goal of the business, society and the public authorities, was to guarantee congruity in the inventory of basic, life-saving meds that are fundamental for limiting medical issues during the pandemic.
- Article View: 131
- PDF Download: 422